BR in Patients With CLL With Comorbidities and/or Renal Dysfunction

NCT01832922 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

Interventions

DRUG: Bendamustine
DRUG: Rituximab

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]